Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators

Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators

US Patent 11299494 · Granted Apr 12, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide 2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Amide-substituted heterocyclic compounds for the treatment of conditions related2025
Pharmaceutical compositions comprising WRN helicase inhibitors2025
Aminotriazolopyridines as kinase inhibitors2024
Triazolopyridinyl compounds as kinase inhibitors2024
Substituted thienopyrroles as PAD4 inhibitors2024
Substituted heterocyclic compounds2024
Substituted heterocyclic compounds2024
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2023
Triazolopyridinyl compounds as kinase inhibitors2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 2023